Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Drug Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2018-2034)
2.2 Oncolytic Virus Drug Treatment Growth Trends by Region
2.2.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2018-2023)
2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2024-2034)
2.3 Oncolytic Virus Drug Treatment Market Dynamics
2.3.1 Oncolytic Virus Drug Treatment Industry Trends
2.3.2 Oncolytic Virus Drug Treatment Market Drivers
2.3.3 Oncolytic Virus Drug Treatment Market Challenges
2.3.4 Oncolytic Virus Drug Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue
3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2018-2023)
3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Drug Treatment Revenue
3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio
3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2024
3.5 Oncolytic Virus Drug Treatment Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Drug Treatment Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Drug Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Drug Treatment Breakdown Data by Type
4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Type (2018-2023)
4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2024-2034)
5 Oncolytic Virus Drug Treatment Breakdown Data by Application
5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2018-2023)
5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Oncolytic Virus Drug Treatment Market Size (2018-2034)
6.2 North America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
6.4 North America Oncolytic Virus Drug Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Drug Treatment Market Size (2018-2034)
7.2 Europe Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
7.4 Europe Oncolytic Virus Drug Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2018-2034)
8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2018-2034)
9.2 Latin America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
9.4 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2018-2034)
10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Phase 1
Table 3. Key Players of Phase 2
Table 4. Key Players of Others
Table 5. Global Oncolytic Virus Drug Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Oncolytic Virus Drug Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Oncolytic Virus Drug Treatment Market Share by Region (2018-2023)
Table 9. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Oncolytic Virus Drug Treatment Market Share by Region (2024-2034)
Table 11. Oncolytic Virus Drug Treatment Market Trends
Table 12. Oncolytic Virus Drug Treatment Market Drivers
Table 13. Oncolytic Virus Drug Treatment Market Challenges
Table 14. Oncolytic Virus Drug Treatment Market Restraints
Table 15. Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Oncolytic Virus Drug Treatment Market Share by Players (2018-2023)
Table 17. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2024)
Table 18. Ranking of Global Top Oncolytic Virus Drug Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Drug Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncolytic Virus Drug Treatment Product Solution and Service
Table 22. Date of Enter into Oncolytic Virus Drug Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2024-2034)
Table 28. Global Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2024-2034)
Table 32. North America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Oncolytic Virus Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Oncolytic Virus Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Oncolytic Virus Drug Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Oncolytic Virus Drug Treatment Product
Table 50. Amgen Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Oncolytics Biotech Company Detail
Table 53. Oncolytics Biotech Business Overview
Table 54. Oncolytics Biotech Oncolytic Virus Drug Treatment Product
Table 55. Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 56. Oncolytics Biotech Recent Development
Table 57. Viralytics Company Detail
Table 58. Viralytics Business Overview
Table 59. Viralytics Oncolytic Virus Drug Treatment Product
Table 60. Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 61. Viralytics Recent Development
Table 62. Transgene SA Company Detail
Table 63. Transgene SA Business Overview
Table 64. Transgene SA Oncolytic Virus Drug Treatment Product
Table 65. Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 66. Transgene SA Recent Development
Table 67. Oncolys BioPharma Company Detail
Table 68. Oncolys BioPharma Business Overview
Table 69. Oncolys BioPharma Oncolytic Virus Drug Treatment Product
Table 70. Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 71. Oncolys BioPharma Recent Development
Table 72. Targovax Company Detail
Table 73. Targovax Business Overview
Table 74. Targovax Oncolytic Virus Drug Treatment Product
Table 75. Targovax Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 76. Targovax Recent Development
Table 77. PsiOxus Therapeutics Company Detail
Table 78. PsiOxus Therapeutics Business Overview
Table 79. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product
Table 80. PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 81. PsiOxus Therapeutics Recent Development
Table 82. SillaJen Biotherapeutics Company Detail
Table 83. SillaJen Biotherapeutics Business Overview
Table 84. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product
Table 85. SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 86. SillaJen Biotherapeutics Recent Development
Table 87. Sorrento Therapeutics Company Detail
Table 88. Sorrento Therapeutics Business Overview
Table 89. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product
Table 90. Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 91. Sorrento Therapeutics Recent Development
Table 92. Lokon Pharma Company Detail
Table 93. Lokon Pharma Business Overview
Table 94. Lokon Pharma Oncolytic Virus Drug Treatment Product
Table 95. Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 96. Lokon Pharma Recent Development
Table 97. Genelux Corporation Company Detail
Table 98. Genelux Corporation Business Overview
Table 99. Genelux Corporation Oncolytic Virus Drug Treatment Product
Table 100. Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 101. Genelux Corporation Recent Development
Table 102. Vyriad Company Detail
Table 103. Vyriad Business Overview
Table 104. Vyriad Oncolytic Virus Drug Treatment Product
Table 105. Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 106. Vyriad Recent Development
Table 107. TILT Biotherapeutics Company Detail
Table 108. TILT Biotherapeutics Business Overview
Table 109. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product
Table 110. TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 111. TILT Biotherapeutics Recent Development
Table 112. Cold Genesys Company Detail
Table 113. Cold Genesys Business Overview
Table 114. Cold Genesys Oncolytic Virus Drug Treatment Product
Table 115. Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 116. Cold Genesys Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Drug Treatment Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Oncolytic Virus Drug Treatment Market Share by Type: 2024 VS 2034
Figure 3. Phase 1 Features
Figure 4. Phase 2 Features
Figure 5. Others Features
Figure 6. Global Oncolytic Virus Drug Treatment Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Oncolytic Virus Drug Treatment Market Share by Application: 2024 VS 2034
Figure 8. Melanoma Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Oncolytic Virus Drug Treatment Report Years Considered
Figure 14. Global Oncolytic Virus Drug Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Oncolytic Virus Drug Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Oncolytic Virus Drug Treatment Market Share by Region: 2024 VS 2034
Figure 17. Global Oncolytic Virus Drug Treatment Market Share by Players in 2024
Figure 18. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Drug Treatment Revenue in 2024
Figure 20. North America Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Oncolytic Virus Drug Treatment Market Share by Country (2018-2034)
Figure 22. United States Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Oncolytic Virus Drug Treatment Market Share by Country (2018-2034)
Figure 26. Germany Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Oncolytic Virus Drug Treatment Market Share by Region (2018-2034)
Figure 34. China Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Oncolytic Virus Drug Treatment Market Share by Country (2018-2034)
Figure 42. Mexico Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Share by Country (2018-2034)
Figure 46. Turkey Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 49. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 50. Viralytics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 51. Transgene SA Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 52. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 53. Targovax Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 54. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 55. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 56. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 57. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 58. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 59. Vyriad Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 60. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 61. Cold Genesys Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed